PE n = 48 | VTE n = 72 | No VTE n = 511 | p-value* | |
---|---|---|---|---|
Male:female | (47.9):(52.1) | (45.8):(54.2) | (54.4):(45.6) | 0.17a |
Agex, years | 71.3 ± 9.6 | 70.3 ± 9.8 | 68.1 ± 11.2 | 0.11b |
Active malignant disease | 20/48 (41.7) | 30/72 (41.7) | 192/511 (37.6) | 0.50a |
Heart disease | 25/48 (52.1) | 35/72 (48.6) | 197/511 (38.6) | 0.10a |
Impaired left ventricular systolic function | 3/48 (6.3) | 4/72 (5.6) | 31/511 (6.1) | 1.00c |
Atrial fibrillation | 5/48 (10.4) | 8/72 (11.1) | 83/511 (16.2) | 0.26a |
Significant aortic or mitral valve disease | 5/48 (10.4) | 6/72 (8.3) | 40/511 (7.8) | 0.88a |
Left ventricular hypertrophy | 7/48 (14.6) | 14/72 (19.4) | 76/511 (14.9) | 0.31a |
No: mild to moderate: moderately severe: ≥ severe airway obstruction | (63.0):(21.7):(10.9):(4.4) | (70.0):(18.6):(8.6):(2.9) | (62.5):(13.8):(13.0):(10.7) | 0.10a |
Pulmonary hypertension | 16/48 (33.3) | 19/72 (26.4) | 71/511 (13.9) | <0.01a |